Suppr超能文献

相似文献

1
Role of IL-2 secreted by PADRE-specific CD4+ T cells in enhancing E7-specific CD8+ T-cell immune responses.
Gene Ther. 2008 May;15(9):677-87. doi: 10.1038/sj.gt.3303102. Epub 2008 Feb 14.
2
Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer.
Gene Ther. 2011 Mar;18(3):304-12. doi: 10.1038/gt.2010.151. Epub 2010 Oct 28.

引用本文的文献

1
Studies on nanoprotein vaccine alleviating symptoms of mice allergic to rFel d 1.
Front Immunol. 2025 May 26;16:1524929. doi: 10.3389/fimmu.2025.1524929. eCollection 2025.
2
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy.
Cancer Immunol Immunother. 2024 Oct 3;73(12):245. doi: 10.1007/s00262-024-03830-2.
3
Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.
Hum Gene Ther. 2018 Sep;29(9):971-996. doi: 10.1089/hum.2017.197. Epub 2018 Mar 16.
4
Peptide vaccines in cancer-old concept revisited.
Curr Opin Immunol. 2017 Apr;45:1-7. doi: 10.1016/j.coi.2016.11.001. Epub 2016 Dec 9.
5
Cancer immunotherapy employing an innovative strategy to enhance CD4+ T cell help in the tumor microenvironment.
PLoS One. 2014 Dec 22;9(12):e115711. doi: 10.1371/journal.pone.0115711. eCollection 2014.
6
Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection.
Vaccine. 2012 Mar 9;30(12):2178-86. doi: 10.1016/j.vaccine.2012.01.012. Epub 2012 Jan 26.
7
Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer.
Gene Ther. 2011 Mar;18(3):304-12. doi: 10.1038/gt.2010.151. Epub 2010 Oct 28.
8
Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909.
Cancer Immunol Immunother. 2011 Feb;60(2):161-71. doi: 10.1007/s00262-010-0929-7. Epub 2010 Oct 21.
9
Immunotherapy for cervical cancer: Research status and clinical potential.
BioDrugs. 2010 Apr 1;24(2):109-29. doi: 10.2165/11532810-000000000-00000.
10
DNA vaccines for cervical cancer.
Am J Transl Res. 2010 Jan 2;2(1):75-87.

本文引用的文献

1
Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.
Expert Rev Vaccines. 2007 Apr;6(2):227-39. doi: 10.1586/14760584.6.2.227.
3
Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion.
Cancer Res. 2007 Feb 15;67(4):1832-41. doi: 10.1158/0008-5472.CAN-06-3014.
4
Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice.
Gene Ther. 2007 Jan;14(1):20-9. doi: 10.1038/sj.gt.3302840. Epub 2006 Aug 17.
5
Cooperation between CD4+ and CD8+ T cells: when, where, and how.
Annu Rev Immunol. 2006;24:519-40. doi: 10.1146/annurev.immunol.23.021704.115825.
6
A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells.
J Immunol. 2005 Jun 15;174(12):7497-505. doi: 10.4049/jimmunol.174.12.7497.
7
Helping the CD8(+) T-cell response.
Nat Rev Immunol. 2004 Aug;4(8):595-602. doi: 10.1038/nri1413.
8
Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes.
Nat Immunol. 2003 Jun;4(6):579-85. doi: 10.1038/ni928. Epub 2003 May 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验